Tecan Group AG (LON:0QLN)

Market Cap	2.31B
Revenue (ttm)	880.60M
Net Income (ttm)	89.23M
Shares Out	n/a
EPS (ttm)	6.95
PE Ratio	25.92
Forward PE	n/a
Dividend	2.67 (1.30%)
Ex-Dividend Date	Apr 22, 2024

Volume	4,499
Average Volume	9,024
Open	206.40
Previous Close	206.60
Day's Range	204.60 - 208.40
52-Week Range	204.60 - 412.60
Beta	0.75
RSI	34.17
Earnings Date	Mar 12, 2025

About Tecan Group AG

Tecan Group AG provides laboratory instruments and solutions for pharmaceutical, biotechnology and in-vitro diagnostic companies, university research departments, and diagnostic and other laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and antibodies, and software; and Tecan Labwerx, an automation solution. It provides PARAMIT, a contract design and manufacturing service. The compa...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1980
• Employees: 3,573
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QLN

Financial Performance

In 2023, Tecan Group AG's revenue was 1.07 billion, a decrease of -6.11% compared to the previous year's 1.14 billion. Earnings were 132.08 million, an increase of 9.04%.

Financial numbers in CHF